Nevro (NYSE: NVRO) reported Q4 EPS of ($0.44), $0.18 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $114.4 million versus the consensus estimate of $111.8 million.

GUIDANCE:

Nevro sees FY2020 revenue of $435-440 million, versus the consensus of $437.06 million.

• In addition, the Company provided additional full year 2020 guidance as follows: Gross margin is expected to be in the range of 69% to 70% and operating expenses are expected to be approximately $355 million, including litigation expenses. To assist investors in understanding Nevro's underlying business trends, the Company is also introducing adjusted EBITDA guidance of positive $3.0 to $10.0 million for the full year 2020, which compares to a loss of $40.3 million in 2019. Adjusted EBITDA excludes certain litigation expenses, interest, taxes and non-cash items such as stock-based compensation and depreciation and amortization. Please see financial tables for GAAP to Non-GAAP reconciliations.

For earnings history and earnings-related data on Nevro (NVRO) click here.